Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells.

Saved in:
Bibliographic Details
Title: Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells.
Authors: Chung SS; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA., Dutta P; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA., Austin D; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA., Wang P; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA., Awad A; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA., Vadgama JV; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA.; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
Source: Oncotarget [Oncotarget] 2018 Aug 31; Vol. 9 (68), pp. 32943-32957. Date of Electronic Publication: 2018 Aug 31 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.25993